Antibacterial and antibiofilm activities of tryptoquivalines and meroditerpenes isolated from the marine-derived fungi Neosartorya paulistensis, N. laciniosa, N. tsunodae, and the soil fungi N. fischeri and N. siamensis

Marine Drugs

Volumn 12, Issue 2, 2014, Pages 822-839

  Gomes, Nelson M ^a,b   Bessa, Lucinda J ^a,b   Buttachon, Suradet ^a,b   Costa, Paulo M ^a,b   Buaruang, Jamrearn ^c   Dethoup, Tida ^d   Silva, Artur M S ^e   Kijjoa, Anake ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c RAMKHAMHAENG UNIVERSITY   (Thailand)

^d KASETSART UNIVERSITY   (Thailand)

^e UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Antibacterial; Antibiofilm; Marine derived fungi; Meroditerpenes; Multidrug resistant; Neosartorya; Tryptoquivalines

Indexed keywords

3' (4 OXOQUINAZOLIN 3 YL) SPIRO [1H INDOLE 3,5'] 2,2' DIONE; 4(3H) QUINAZOLINONE; AMPICILLIN; ANTIBIOTIC AGENT; ASZONAPYRONES A; ASZONAPYRONES B; CHEVALONES B; CHEVALONES C; CIPROFLOXACIN; MERODITERPENE DERIVATIVE; OXACILLIN; SARTORYPYRONE C; SARTORYPYRONES A; SARTORYPYRONES B; TRYPTOQUIVALINE DERIVATIVE; TRYPTOQUIVALINES F; TRYPTOQUIVALINES H; TRYPTOQUIVALINES L; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; DISK DIFFUSION; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FUNGUS CULTURE; MARINE SPECIES; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEOSARTORYA; NEOSARTORYA FISCHERI; NEOSARTORYA LACINIOSA; NEOSARTORYA PAULISTENSIS; NEOSARTORYA SIAMENSIS; NEOSARTORYA TSUNODAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SOIL ORGANISM; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; DITERPENES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; INDOLES; MICROBIAL SENSITIVITY TESTS; NEOSARTORYA; PORIFERA; SOIL MICROBIOLOGY;

EID: 84896718606     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12020822     Document Type: Article

References (25)

1. Johnson, A.P.; Livermore, D.M.; Tillotson, G.S. Antimicrobial susceptibility of Gram-positive bacteria: What's current, what's anticipated? J. Hosp. Infect. 2001, 49, S3-S11.
2. Aksoy, D.Y.; Unal, S. New antimicrobial agents for treatment of Gram-positive bacterial infections. Clin. Microbiol. Infect. 2008, 14, 411-420.
3. Aziz, A.M. The role of healthcare strategies in controlling antibiotic resistance. Br. J. Nurs. 2013, 22, 1066-1074.
4. Bassetti, M.; Merelli, M.; Temperoni, C.; Astilean, A. New antibiotics for bad bugs: Where are we? Ann. Clin. Microbiol. Antimicrob. 2013, 12, doi:10.1186/1476-0711-12-22.
5. Kijjoa, A.; Sawangwong, P. Drugs and Cosmetics from the Sea. Mar. Drugs 2004, 2, 73-82.
6. Newman, D.J.; Cragg, G.M. Natural Products as Sources of New Drugs over the 30 Years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
7. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.G.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2013, 30, 237-323.
8. Rowley, D.C.; Kelly, S.; Kauffman, C.A.; Jensen P.R.; Fenical, W. Halovirs A-E, new antiviral agents from a marine-derived fungus of the genus Scytalidium. Bioorg. Med. Chem. 2003, 11, 4263-4274.
9. Shen, S.; Li, W.; Ouyang, M.A.; Wu, Z.J.; Lin, Q.Y.; Xie, L.H. Identification of two marine fungi and evaluation of their antivirus and antitumor activities. Acta Microbiol. Sin. 2009, 49, 1240-1246.
10. Bugni, T.S.; Ireland, C.M. Marine-derived fungi: A chemically and biologically diverse group of microorganisms. Nat. Prod. Rep. 2004, 21, 143-163.
11. Pejin, B.; Jovanović, K.K.; Mojović, M.; Savić, A.G. New and highly potent antitumor natural products from marine-derived fungi: Covering the period from 2003 to 2012. Curr. Top. Med. Chem. 2013, 13, 2745-2766.
12. Christophersen, C.; Crescente, C.; Frisvad, J.C.; Gram, L.; Nielsen, J.; Nielsen, P.H.; Rahbæk, L. Antibacterial activity of marine-derived fungi. Mycopathologia 1999, 143, 135-138.
13. Arasu, M.V.; Duraipandiyan, V.; Ignacimuthu, S. Antibacterial and antifungal activities of polyketide metabolite from marine Streptomyces sp. AP-123 and its cytotoxic effect. Chemosphere 2013, 90, 479-487.
14. Manimegalai, K.; Devi, N.K.A.; Padmavathy, S. Marine fungi as a source of secondary metabolites of antibiotics. Int. J. Biotechnol. Bioeng. Res. 2013, 4, 275-282.
15. Eamvijarn, A.; Gomes, N.M.; Dethoup, T.; Buaruang, J.; Manoch, L.; Silva, A.; Pedro, M.; Marini, I.; Roussis, V.; Kijjoa, A. Bioactive meroditerpenes and indole alkaloids from the soil fungus Neosartorya fischeri (KUFC 6344), and the marine-derived fungi Neosartorya laciniosa (KUFC 7896) and Neosartorya tsunodae (KUFC 9213). Tetrahedron 2013, 69, 8583-8591.
16. Buttachon, S.; Chandrapatya, A.; Manoch, L.; Silva, A.; Gales, L.; Bruyére, C.; Kiss, R.; Kijjoa, A. Sartorymensin, a new indole alkaloid, and new analogues of tryptoquivaline and fiscalins produced by Neosartorya siamensis (KUFC 6349). Tetrahedron 2012, 68, 3253-3262.
17. Mahato, S.B.; Kundu, A.P. 13C NMR spectra of pentacyclic triterpenoids - a compilation and some salient feature. Phytochemistry 1994, 37, 1517-1575.
18. Hoffman, L.R.; D'Argenio, D.A.; MacCoss, M.J.; Zhang, Z.; Jones, R.A.; Miller, S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005, 436, 1171-1175.
19. Kaplan, J.B.; Jabbouri, S.; Sadovskaya, I. Extracellular DNA-dependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics. Res. Microbiol. 2011, 162, 535-541.
20. Bessa, L.J.; Grande, R.; Di Iorio, D.; Di Giulio, M.; Di Campli, E.; Cellini, L. Helicobacter pylori free-living and biofilm modes of growth: Behavior in response to different culture media. APMIS 2013, 121, 549-560.
21. Glass, N.L., Donaldson, G.C. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl. Environ. Microbiol. 1995, 61, 1323-1330.
22. Kulkarni, S.S.; Singh, S.; Shah, J.R.; Low, W. K.; Talele, T.T. Synthesis and SAR optimization of quinazolin-4(3 H)-ones as poly(ADP-ribose)polymerase-1 inhibitors. Eur. J. Med. Chem. 2012, 50, 264-273.
23. Franklin, R.; Cockerill, M.D., III. Performance Standards for Antimicrobial Susceptibility Testing, Twenty-First Informational Supplement M100-S21; Clinical and Laboratory Standards Institute (CLSI): Wayne, PA, USA, 2011.
24. Odds, F.C. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 2003, 52, doi:10.1093/jac/dkg301.
25. Johnson, S.A.; Goddard, P.A.; Iliffe, C.; Timmins, B.; Rickard, A.H.; Robson, G.; Handley, P.S. Comparative susceptibility of resident and transient hand bacteria to para-chloro-meta-xylenol and triclosan. J. Appl. Microbiol. 2002, 93, 336-344.